Clinical Study Results Sanofi Pharma, including Sanofi Genzyme



Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter E

Generic Name Trade Name Condition Study Code Study Name Access to study Access to results
ELIGLUSTAT TARTRATE Cerdelga Gaucher Disease ACC14373 NA NCT02422654
ELIGLUSTAT TARTRATE Cerdelga Gaucher Disease GZGD00304 NA NCT00358150
ELIGLUSTAT TARTRATE Cerdelga Gaucher Disease GZGD02507 ENGAGE NCT00891202
ELIGLUSTAT TARTRATE Cerdelga Gaucher Disease GZGD02607 ENCORE NCT00943111
ELIGLUSTAT TARTRATE Cerdelga Gaucher Disease GZGD03109 EDGE NCT01074944
ENOXAPARIN SODIUM Lovenox Thromboprophylaxis EFC10094 NA NCT00723216
ENOXAPARIN SODIUM Lovenox Myocardial Infarction, Acute EFC6147 EXTRACT NCT00077792
ENOXAPARIN SODIUM Lovenox Prevention VTE in Orthopaedic Surgery EFC6770 NA NCT00349180
ENOXAPARIN SODIUM Lovenox Myocardial Infarction, Non-ST-Segment Elevation Angina, Unstable ENO_GMA_301 SYNERGY NCT00043784
ENOXAPARIN SODIUM Lovenox Acute Illness ENOXA_C_01249 LIFENOX NCT00622648
ENOXAPARIN SODIUM Lovenox Thrombosis ENOXA_C_02537 NA NCT00622115
ENOXAPARIN SODIUM Lovenox Prevention VTE in Orthopaedic Surgery SFY6771 NA NCT00685958
ENOXAPARIN SODIUM Lovenox Percutaneous Coronary Intervention XRP4563_4001 STEEPLE NCT00077844
ENOXAPARIN SODIUM Lovenox Renal Dialysis ENOXA_L_00821 HENOX NCT00347490
ENOXAPARIN SODIUM Lovenox Thromboembolism, Venous (VTE) XRP4563A_4001 TROMBOTEK NCT00265993
ENOXAPARIN SODIUM Lovenox Cardiovascular Diseases XRP4563B_4001 RESCUE NCT00077818
ENOXAPARIN SODIUM Lovenox Medical Prevention Therapy XRP4563C_3501 EXCLAIM NCT00077753
ENOXAPARIN SODIUM Lovenox Cardiovascular Diseases XRP4563H_4001 PREVAIL NCT00077805
EPLIVANSERIN Not marketed Pain, Sleep Disorders, Fibromyalgia ACT5400 NA NCT00313885
EPLIVANSERIN Not marketed Sleep disorders EFC10480 DREAMS EudraCT: 2007-003822-28
EPLIVANSERIN Not marketed Insomnia EFC10844 ECLIPSE EudraCT: 2008-003791-22
EPLIVANSERIN Not marketed Sleep disorders EFC6220 EPOCH NCT00308503
EPLIVANSERIN Not marketed Sleep disorders LTE6217 GEMS EudraCT: 2005-003080-23
EPLIVANSERIN Not marketed Sleep disorders LTE6262 EPLILONG EudraCT: 2005-003082-16
EPLIVANSERIN Not marketed Sleep disorders PKD10491 PKiDs NCT00913614


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted